Salem, Hesham, Samir, Ebtihal, Abdelaziz, Amany, Alaa El-din, Mahmoud, Abdelgaleel, Mahmoud, Zein, Dina, Madian, Hoda (2021) Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 262. 120066 doi:10.1016/j.saa.2021.120066
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids | ||
Journal | Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy | ||
Authors | Salem, Hesham | Author | |
Samir, Ebtihal | Author | ||
Abdelaziz, Amany | Author | ||
Alaa El-din, Mahmoud | Author | ||
Abdelgaleel, Mahmoud | Author | ||
Zein, Dina | Author | ||
Madian, Hoda | Author | ||
Year | 2021 (December) | Volume | 262 |
Publisher | Elsevier BV | ||
DOI | doi:10.1016/j.saa.2021.120066Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 16403725 | Long-form Identifier | mindat:1:5:16403725:0 |
GUID | 0 | ||
Full Reference | Salem, Hesham, Samir, Ebtihal, Abdelaziz, Amany, Alaa El-din, Mahmoud, Abdelgaleel, Mahmoud, Zein, Dina, Madian, Hoda (2021) Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 262. 120066 doi:10.1016/j.saa.2021.120066 | ||
Plain Text | Salem, Hesham, Samir, Ebtihal, Abdelaziz, Amany, Alaa El-din, Mahmoud, Abdelgaleel, Mahmoud, Zein, Dina, Madian, Hoda (2021) Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 262. 120066 doi:10.1016/j.saa.2021.120066 | ||
In | (2021) Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy Vol. 262. Elsevier BV |
See Also
These are possibly similar items as determined by title/reference text matching only.